Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect
Peng-Sheng Yi, Chen-Jun Hu, Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
Chen-Hui Li, Department of Obstetrics and Gynecology, Nanchong Traditional Chinese Medicine Hospital, Nanchong 637000, Sichuan Province, China
Fei Yu, Department of Radiology, Yingshan County People’s Hospital, Nanchong 610041, Sichuan Province, China
Author contributions: Yu F proposed the idea; Yi PS and Hu CJ wrote the manuscript; Yi PS and Hu CJ contributed equally to this work; Li CH performed the electronic searching and abstracted the data.
Supported by Project of Science and Technology Department of Sichuan Province, No. 2018JY050; and Nanchong Science and Technology Bureau Project, No. 18SXHZ0336.
Conflict-of-interest statement: The authors declare that they have no competing interests.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Fei Yu, MD, Professor, Department of Radiology, Yingshan County People’s Hospital, No. 100 Danan Street, Yingshan County, Nanchong 610041, Sichuan Province, China. email@example.com
Received: January 6, 2021
Peer-review started: January 6, 2021
First decision: February 14, 2021
Revised: February 25, 2021
Accepted: March 15, 2021
Article in press: March 15, 2021
Published online: April 28, 2021